The natural history of type 2 diabetes. Implications for clinical practice.
about
Role of bile acid sequestrants in the treatment of type 2 diabetesHbA1c measured in stored erythrocytes is positively linearly associated with mortality in individuals with diabetes mellitusIncidence rates and predictors of diabetes in those with prediabetes: the Strong Heart StudyPlasma Protein Biomarkers Correlated with the Development of Diet-Induced Type 2 Diabetes in Mice.Emerging treatment options for type 2 diabetesPrevalence of dysglycemia in Calabar: a cross-sectional observational study among residents of Calabar, Nigeria.Genetic determinants of type 2 diabetes mellitus.Medical care from childhood to adulthood in type 1 and type 2 diabetes.Outcomes in the offspring of mothers with pre-diabetes during pregnancy: a protocol for a systematic review.Glycemic control over 5 years in 4,900 people with type 2 diabetes: real-world diabetes therapy in a clinical trial cohort.ACE2 deficiency reduces β-cell mass and impairs β-cell proliferation in obese C57BL/6 miceRole of PTEN in Oxidative Stress and DNA Damage in the Liver of Whole-Body Pten Haplodeficient MiceHelminths, hygiene hypothesis and type 2 diabetes.National Trends in Treatment Initiation for Nursing Home Residents With Diabetes Mellitus, 2008 to 2010Thiazolidinedione derivatives in diabetes and cardiovascular disease: an update.Insulin resistance in Nigerians with essential hypertensionSitagliptin and metformin--novel combination therapy.Crossover design and its application in late-phase diabetes studies.An algorithm for the treatment of type 2 diabetes in Latin America.Admission hyperglycemia predicts poorer short- and long-term outcomes after primary percutaneous coronary intervention for ST-elevation myocardial infarction.Determinants of Long-Term Durable Glycemic Control in New-Onset Type 2 Diabetes MellitusRecent population changes in HbA(1c) and fasting insulin concentrations among US adults with preserved glucose homeostasis.A new look at established therapies: practical tools for optimizing insulin use.[Potential therapeutic approaches for prevention and treatment of diabetic nephropathy and neuropathy: evidences of cilostazol].Effects of psychotropics on glycosylated hemoglobin (HbA1c) in a cohort of bipolar patients.Macular thinning in prediabetes or type 2 diabetes without diabetic retinopathy: the Maastricht Study.Prediabetes awareness among Southeastern European physicians.Long-term patterns of fasting blood glucose levels and pancreatic cancer incidence.Preventing diabetes complications and the "glucocentric" dilemma: a word of caution.Periodontitis is associated with aggravation of prediabetes in Zucker fatty rats.Efficacy and tolerability of novel triple combination therapy in drug-naïve patients with type 2 diabetes from the TRIPLE-AXEL trial: protocol for an open-label randomised controlled trial
P2860
Q28236411-9B711BC3-3311-4BC5-8693-8B00C4BB46B1Q28728521-5CE009A5-17B4-42A4-915F-655267CA40D2Q33965429-687A74B8-33B1-40C4-A947-2778C1022BD4Q33973509-66C2B980-0B25-4E32-B71A-A743BDB38691Q34381281-C6BF953D-DF30-4C91-82FD-48DE99D4523DQ34419188-FD403320-844A-4F6F-8F69-89CCA1A25EB3Q34421519-42ACF85E-FCB8-436E-AD65-0A8125BB0E37Q34444323-F4FA694F-44D5-41E3-B6B5-40D8FD76125CQ35601063-4BA13710-38DA-4BDC-A567-C8EB7BFDE074Q35898200-934C0FAF-D3F2-43D7-9B20-E7A81A53CBE7Q36122624-371761E3-770F-4B0A-9EFF-BFD74201D7E4Q36205532-75B5C2C1-5DAA-4D1E-A6A9-F8DD18AE359DQ36214734-5A1B4587-F3E0-40F0-9146-5B12080A2C23Q37048008-41AE4F3B-6E19-4C47-BBEC-CDE82CAA0A7DQ37142138-A1216A13-2E41-450F-8D42-EE86370C2C28Q37299014-BEDF9285-CB12-4BF9-B158-1167CF91EA19Q37835284-72773920-E193-4CCE-8239-D72AE090EDDAQ38813734-BBED851B-C111-4907-9689-A99A4287B2AAQ39708004-38B1A14C-07F6-4C95-9EED-092D76154BC8Q39719274-85606C8B-E5D3-41C7-8405-912BB227C976Q41607278-BB7E7EE7-3224-4B10-BA4C-F8D35B9265B0Q43047417-546FABA2-18EB-4EF6-B008-EAA20EADD59AQ43050598-F68DC74E-DBC9-4837-A3E9-D84EE49B9A2DQ46798121-213AE460-5531-4FC9-9F69-79EF2CD00A3EQ46910754-6ACEDB83-0098-4C16-BC4D-0C57968E9F4EQ48090307-3E05F5E5-A1FA-4E50-B349-1E8EC9425747Q48156687-D97C5CC7-7963-4770-89F2-8F39F4573563Q48190589-53EBEEB9-3A4D-44A2-98DF-8642BAFF7572Q50648548-3FB55996-FE63-401B-AE90-697AF0401FE7Q51476467-A8AC3020-5680-4F59-A0C5-1F367F859A5AQ58700185-5AE43F12-8339-4210-8698-FE8C5880AA37
P2860
The natural history of type 2 diabetes. Implications for clinical practice.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The natural history of type 2 diabetes. Implications for clinical practice.
@ast
The natural history of type 2 diabetes. Implications for clinical practice.
@en
type
label
The natural history of type 2 diabetes. Implications for clinical practice.
@ast
The natural history of type 2 diabetes. Implications for clinical practice.
@en
prefLabel
The natural history of type 2 diabetes. Implications for clinical practice.
@ast
The natural history of type 2 diabetes. Implications for clinical practice.
@en
P1476
The natural history of type 2 diabetes. Implications for clinical practice.
@en
P2093
Edelman SV
Ramlo-Halsted BA
P304
P356
10.1016/S0095-4543(05)70130-5
P577
1999-12-01T00:00:00Z